The early detection of cancer can significantly reduce cancer mortality and saves lives. Thus,
a great deal of effort has been devoted to the exploration of new technologies to detect early …

The introduction of technologies such as mass spectrometry and protein and DNA arrays,
combined with our understanding of the human genome, has enabled simultaneous …

Cancer is a major global health burden and poor survival rates can be attributed to lack of
early diagnosis and limited access to timely and standard treatments. Significant progress …

Cancer is one of the major public health problems worldwide representing the leading
cause of morbidity and mortality in industrialized countries. To reduce cancer morbidity and …

Biomarkers provide a powerful and dynamic approach to understanding the spectrum of
malignancies with applications in observational and analytic epidemiology, randomized …

Background: Precision medicine puts forward customized healthcare for cancer patients. An
important way to accomplish this task is to stratify patients into those who may respond to a …

BACKGROUND Protein cancer biomarkers serve multiple clinical purposes, both early and
late, during disease progression. The search for new and better biomarkers has become an …

Diagnostic detection and measurement of cancer disease progression are essential
elements for successful cancer disease management. The early stages of cancer …

In spite of advances in diagnostics and therapeutics, cancer remains the second leading
cause of death in the US Successful cancer treatment depends not only on better therapies …

With the availability of new technologies and the increased interest of medical practitioners
to use molecular biomarkers in early detection and diagnosis, and in the prediction of …